AMN Healthcare Services, Inc.

NYSE:AMN

Medical - Care Facilities

Healthcare
$37.60 -3.98%

-$1.29 today

Market cap
$1.45B
Beta
0.44
P/E (TTM)
-37.3
EPS (TTM)
-$0.83
52W Low $14.87High $33.13

Volume 0.55M

Average 1.02M

AMN Debt Repayment

Cash used to repay borrowings during the period.

AMN Healthcare Services, Inc.NYSE: AMN

Debt Repayment · Q1 FY2026 · quarter ended Mar 2026

Debt repayment declines year over year

Q1 FY2026 debt repayment of $25M (cash outflow) fell 58.3% year over year, behind the -9.1% change in trailing-twelve-month debt repayment. Sequentially, it fell 66.7% from the prior quarter.

Context

  • Debt repayment amounted to 10.4% of revenue in FY2025, up 2.1 pp from a year earlier.
  • Debt repayment increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -58.3% toward the trailing-twelve-month pace of -9.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$25M-66.7% QoQ
Last fiscal yearDec 2025
-$285M+14.0% YoY
LTMMar 2026
-$250M-9.1% YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-58.3%——
1 year+14.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
(285M) USD
Year-over-year change
-14.0%

Debt Repayment vs competitors

How AMN compares with its peers on the latest reported figures

  • AMN's LTM Mar 2026 debt repayment of $250M is the largest of the 11 companies compared; the peer median is $433.5K.
  • Its year-over-year change of -9.1% is the 4th highest of 8, against a peer median of -36.2%.
  • Debt repayment amounts to 7.3% of revenue for AMN, versus a peer median of 3.8%.
AMN Competitors Peer median
Debt Repayment for AMN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMNAMN Healthcare Services, Inc.LTM Mar 2026$250M -9.1%—7.3%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026$150.17M -36.2%+0.0%71.9%
EVHEvolent Health, Inc.LTM Mar 2026$93.44M -142.9%-33.3%4.9%
MYGNMyriad Genetics, Inc.LTM Mar 2026$64.5M +229.1%—7.8%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$29.2M -1346.3%+193.4%19.2%
NUTXNutex Health, Inc.LTM Mar 2026$23.69M +521.5%+51.5%2.7%
CMPSCOMPASS Pathways plcLTM Mar 2026$18.55M ———
REPLReplimune Group, Inc.LTM Dec 2025$701K +23.6%+31.4%—
DNAGinkgo Bioworks Holdings, Inc.LTM Mar 2026$166K -79.5%-34.1%0.1%
BFLYButterfly Network, Inc.LTM Mar 2026$0 ——0.0%
HSTMHealthStream, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding AMN) $433.5K-36.2%+15.7%3.8%

Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income327.39M444.05M210.68M(146.98M)(95.7M)
Depreciation & Amortization103.7M137.11M160.93M173.78M156.6M
Deferred Income Tax(16.29M)(24.62M)(12.93M)(51.07M)(19.55M)
Stock-Based Compensation25.22M30.07M18.02M23.32M30.68M
Change in Working Capital(143.49M)(558K)(50.13M)85.91M101.03M
Accounts Receivables(585.27M)20.04M224.85M219.44M74.75M
Inventory(256.12M)0000
Accounts Payables256.12M000(20.57M)
Other Working Capital441.77M(20.6M)(274.98M)(133.53M)46.85M
Other Non-Cash Items8.84M67.68M45.6M235.46M96.39M
Operating Cash Flow305.36M653.73M372.17M320.42M269.46M
Capital Expenditures(53.66M)(80.92M)(105.39M)(80.89M)(35.63M)
Acquisitions (Net)(41.26M)(69.5M)(292.1M)065.28M
Purchases of Investments(61.22M)(13.15M)0(1.38M)(36.15M)
Sales of Investments57.74M14.38M9.89M9.1M10.78M
Other Investing Activities(8.99M)(26.61M)(26.6M)(6.76M)22K
Investing Cash Flow(107.4M)(170.71M)(412.49M)(79.94M)4.3M
Debt Repayment(21.88M)0459.7M(250M)(285M)
Common Stock Issued00000
Common Stock Repurchased(2.69M)(576.77M)(424.74M)(8.48M)(2.09M)
Dividends Paid00000
Other Financing Activities(10.33M)(15.1M)(24.23M)(9.45M)(8.8M)
Financing Cash Flow(34.9M)(591.87M)10.73M(259.45M)(295.89M)
Effect of Forex Changes(335K)0000
Net Change in Cash162.72M(108.84M)(29.6M)(18.97M)(22.13M)
Free Cash Flow251.69M572.81M266.78M239.53M233.83M

AMN Healthcare Services, Inc.

NYSE:AMN

Intrinsic Alpha fair value

Locked

Current Price

$37.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.